Abnormal uterine bleeding definition end of cofusion
•Download as PPTX, PDF•
3 likes•517 views
This document discusses the confusion that existed regarding terminology used for menstrual disorders in women. It summarizes the new guidelines developed by FIGO's Menstrual Disorders Working Group to redefine and reclassify menstrual disorders. The FIGO classification system called PALM-COEIN provides standardized terminology to improve communication, research, and education. It defines terms like abnormal uterine bleeding, heavy menstrual bleeding, and post-menstrual bleeding. The hope is this new universal classification of menstrual disorders will end the confusion that previously existed.
Report
Share
Report
Share
Recommended
Abnormal uterine Bleeding
1. The document discusses abnormal uterine bleeding (AUB) and provides classifications and management guidelines.
2. It describes different types of abnormal bleeding patterns and classifications including the FIGO and PALM-COEIN systems.
3. Evaluation and treatment recommendations are provided for various causes of AUB including polyps, adenomyosis, leiomyomas, endometrial hyperplasia/cancer, and coagulopathies.
Abnormal Uterine Bleeding1107 Holm
This document summarizes abnormal uterine bleeding, including its definitions, etiologies, evaluation, and management. It discusses how abnormal uterine bleeding can be caused by systemic, reproductive tract, or dysfunctional issues. Evaluation may involve tests and procedures to determine the cause. Management options include progestins, estrogen, oral contraceptives, NSAIDs, antifibrinolytics, and surgery. Progestins are often the preferred first-line treatment for abnormal uterine bleeding of anovulatory origin.
Abnormal uterine bleeding د رحم غیر نورمال وینه بهیدنه
This document discusses abnormal uterine bleeding (AUB), defined as any abnormalities in menstrual cycle length, flow duration, or amount of bleeding. AUB can occur in women of all ages and is commonly caused by hormonal dysfunction, infections, tumors, or pregnancy complications. The document classifies and describes various patterns of AUB, outlines organic and non-organic causes, and provides recommendations for evaluation and treatment. Physical exam, lab tests, imaging and endometrial biopsy are suggested to determine the cause, with treatment options including medical management or surgical procedures.
Abnormal Uterine Bleeding in Perimenopausal Women
This document summarizes the management of abnormal uterine bleeding in perimenopausal women. It discusses how perimenopause causes irregular menstrual periods due to declining estrogen levels. It describes anovulatory bleeding that can occur when the corpus luteum is not produced. The document introduces the new FIGO classification system for abnormal uterine bleeding and lists common causes like polyps, fibroids, and disorders like adenomyosis. It provides details on diagnostic tests and treatments including medications, intrauterine devices, endometrial ablation, and hormone therapy options. Surgical treatments for heavy menstrual bleeding or postmenopausal bleeding are also summarized.
Abnormal uterine bleeding
This document discusses normal and abnormal menstrual cycles. It notes that a normal cycle is typically 21-35 days with bleeding for 4-7 days. Abnormal bleeding can include irregular spotting or heavy periods. Menopause and certain medical conditions can also cause irregular cycles. Further evaluation depends on a woman's age, symptoms, medical history and physical exam. Tests like ultrasounds and Pap smears may help identify potential causes like fibroids, infections or cancer. Overall irregular bleeding is common but serious issues are usually rare, so evaluation is tailored based on risk factors.
Abnormal uterine bleeding
This document discusses abnormal uterine bleeding (AUB). It begins by defining normal menstrual cycles and explaining the hormonal regulation of menstruation. It then describes different types of abnormal bleeding patterns seen in AUB, including menorrhagia, metrorrhagia, and oligomenorrhoea. Organic and functional causes of AUB are outlined. The document focuses on the pathophysiology, endometrial changes, and management of anovulatory and ovulatory dysfunctional uterine bleeding. Diagnostic tests for AUB and differential diagnoses for adolescents and reproductive-aged women are also reviewed. Treatment options for AUB include medical therapies like hormones and lifestyle modifications, as well as surgical interventions.
Abnormal uterine bleeding
This document presents a case of a 44-year-old woman presenting with abnormal uterine bleeding for 23 days. Her workup showed severe anemia. She was diagnosed with AUB and treated with blood transfusions. Abnormal uterine bleeding is defined as bleeding outside normal volume, duration, or frequency. It can be caused by various structural, hematological, endocrine or other issues. Dysfunctional uterine bleeding is defined as abnormal bleeding without an organic cause, and can be ovulatory or anovulatory. Initial management of AUB involves determining the cause and treating any underlying issues medically or surgically.
Abnormal uterine bleeding
This document discusses irregular vaginal bleeding, including definitions, causes, evaluation, and management. It provides information on what constitutes normal menstrual cycles and bleeding. Causes of irregular bleeding include hormonal contraceptives, endometrial polyps, fibroids, pregnancy-related issues, infections, and cancers. Evaluation involves history, examination, Pap smear, ultrasound, and sometimes hysteroscopy. Management depends on persistence and severity of bleeding, with referral indicated for persistent irregular bleeding after initial evaluation and treatment.
Recommended
Abnormal uterine Bleeding
1. The document discusses abnormal uterine bleeding (AUB) and provides classifications and management guidelines.
2. It describes different types of abnormal bleeding patterns and classifications including the FIGO and PALM-COEIN systems.
3. Evaluation and treatment recommendations are provided for various causes of AUB including polyps, adenomyosis, leiomyomas, endometrial hyperplasia/cancer, and coagulopathies.
Abnormal Uterine Bleeding1107 Holm
This document summarizes abnormal uterine bleeding, including its definitions, etiologies, evaluation, and management. It discusses how abnormal uterine bleeding can be caused by systemic, reproductive tract, or dysfunctional issues. Evaluation may involve tests and procedures to determine the cause. Management options include progestins, estrogen, oral contraceptives, NSAIDs, antifibrinolytics, and surgery. Progestins are often the preferred first-line treatment for abnormal uterine bleeding of anovulatory origin.
Abnormal uterine bleeding د رحم غیر نورمال وینه بهیدنه
This document discusses abnormal uterine bleeding (AUB), defined as any abnormalities in menstrual cycle length, flow duration, or amount of bleeding. AUB can occur in women of all ages and is commonly caused by hormonal dysfunction, infections, tumors, or pregnancy complications. The document classifies and describes various patterns of AUB, outlines organic and non-organic causes, and provides recommendations for evaluation and treatment. Physical exam, lab tests, imaging and endometrial biopsy are suggested to determine the cause, with treatment options including medical management or surgical procedures.
Abnormal Uterine Bleeding in Perimenopausal Women
This document summarizes the management of abnormal uterine bleeding in perimenopausal women. It discusses how perimenopause causes irregular menstrual periods due to declining estrogen levels. It describes anovulatory bleeding that can occur when the corpus luteum is not produced. The document introduces the new FIGO classification system for abnormal uterine bleeding and lists common causes like polyps, fibroids, and disorders like adenomyosis. It provides details on diagnostic tests and treatments including medications, intrauterine devices, endometrial ablation, and hormone therapy options. Surgical treatments for heavy menstrual bleeding or postmenopausal bleeding are also summarized.
Abnormal uterine bleeding
This document discusses normal and abnormal menstrual cycles. It notes that a normal cycle is typically 21-35 days with bleeding for 4-7 days. Abnormal bleeding can include irregular spotting or heavy periods. Menopause and certain medical conditions can also cause irregular cycles. Further evaluation depends on a woman's age, symptoms, medical history and physical exam. Tests like ultrasounds and Pap smears may help identify potential causes like fibroids, infections or cancer. Overall irregular bleeding is common but serious issues are usually rare, so evaluation is tailored based on risk factors.
Abnormal uterine bleeding
This document discusses abnormal uterine bleeding (AUB). It begins by defining normal menstrual cycles and explaining the hormonal regulation of menstruation. It then describes different types of abnormal bleeding patterns seen in AUB, including menorrhagia, metrorrhagia, and oligomenorrhoea. Organic and functional causes of AUB are outlined. The document focuses on the pathophysiology, endometrial changes, and management of anovulatory and ovulatory dysfunctional uterine bleeding. Diagnostic tests for AUB and differential diagnoses for adolescents and reproductive-aged women are also reviewed. Treatment options for AUB include medical therapies like hormones and lifestyle modifications, as well as surgical interventions.
Abnormal uterine bleeding
This document presents a case of a 44-year-old woman presenting with abnormal uterine bleeding for 23 days. Her workup showed severe anemia. She was diagnosed with AUB and treated with blood transfusions. Abnormal uterine bleeding is defined as bleeding outside normal volume, duration, or frequency. It can be caused by various structural, hematological, endocrine or other issues. Dysfunctional uterine bleeding is defined as abnormal bleeding without an organic cause, and can be ovulatory or anovulatory. Initial management of AUB involves determining the cause and treating any underlying issues medically or surgically.
Abnormal uterine bleeding
This document discusses irregular vaginal bleeding, including definitions, causes, evaluation, and management. It provides information on what constitutes normal menstrual cycles and bleeding. Causes of irregular bleeding include hormonal contraceptives, endometrial polyps, fibroids, pregnancy-related issues, infections, and cancers. Evaluation involves history, examination, Pap smear, ultrasound, and sometimes hysteroscopy. Management depends on persistence and severity of bleeding, with referral indicated for persistent irregular bleeding after initial evaluation and treatment.
DUB
This document provides guidance on evaluating abnormal uterine bleeding through history, physical exam, laboratory tests, and imaging. It discusses evaluating for pregnancy, medical illnesses, bleeding disorders, and iatrogenic causes. Differential diagnoses are categorized as organic, dysfunctional, or iatrogenic. Dysfunctional uterine bleeding is considered a diagnosis of exclusion and can be ovulatory or anovulatory. Histopathological findings are described for conditions like irregular proliferation, luteal phase defects, and decidual shedding. Treatment aims and differential diagnoses are discussed based on a patient's age and menopausal status.
Abnormal Uterine Bleeding by Kemi Dele
The document discusses abnormal uterine bleeding, providing definitions and classifications including the PALM-COEIN system. It covers the evaluation, differential diagnosis, and management of abnormal uterine bleeding, both acute and chronic. The evaluation involves history, exam, labs, imaging and other tests to determine the cause, while management depends on whether it is acute or chronic and may involve medical options like hormones or surgery depending on the situation.
Abnormal uterine bleeding (AUB)
This document provides an overview of abnormal uterine bleeding (AUB), including its definition, causes, diagnosis, and treatment. It defines different types of AUB and outlines the FIGO classification system for causes. Common causes in young women include polycystic ovary syndrome (PCOS) and hypothalamic pituitary issues, while older women may experience fibroids, polyps or thyroid problems. Diagnosis involves history, exam, lab tests and imaging to rule out structural issues. Treatment depends on the underlying cause but commonly includes hormonal therapy, non-hormonal medications, endometrial ablation or hysterectomy. Long-term complications can include anemia and increased cancer risk.
ACUTE ABNORMAL UTERINE BLEEDING
1. Acute abnormal uterine bleeding (AUB) requires immediate intervention to prevent blood loss and is evaluated by assessing patient acuity, determining the likely etiology, and choosing appropriate treatment.
2. Initial assessment involves vital signs and signs of hypovolemia while etiologies consider medical history, medications, physical exam, and lab tests.
3. Treatment options for acute AUB include IV conjugated estrogen, intrauterine tamponade, combined oral contraceptives, antifibrinolytics, and surgery if medical options fail or are contraindicated. Long term options treat underlying causes.
Abnormal uterine bleeding
The document summarizes information about the menstrual cycle and abnormal uterine bleeding. It describes the typical phases and hormone levels during a normal menstrual cycle. It then defines and categorizes different types of abnormal uterine bleeding and lists potential structural and non-structural causes. The document outlines evaluation and treatment approaches, including general measures, medical management, minimally invasive procedures, and major surgery.
Abnormal uterine bleeding (aub)
Abnormal uterine bleeding (AUB) is irregular bleeding that occurs without recognizable cause. It reflects disrupted hormonal stimulation of the endometrial lining. AUB is common, especially in adolescents, perimenopausal women, and those with structural issues like polyps or fibroids. Evaluation involves history, exam, labs, and imaging to identify structural or non-structural causes. Treatment depends on severity but commonly includes medical options like birth control pills, NSAIDs, or hormonal drugs before considering surgery.
Abnormal uterine bleeding and Management
The document discusses abnormal uterine bleeding, including definitions of different types and potential causes. It covers evaluation and management of anovulatory bleeding at different reproductive stages. Evaluation may include imaging, biopsy, or testing for disorders. Management involves treating underlying causes, using hormones, or in some cases surgery. Surgical options like hysterectomy are usually only considered if medical management fails and childbearing is complete.
Ppt dub
Dysfunctional uterine bleeding (DUB) is the most common cause of abnormal uterine bleeding in women of reproductive age. DUB can occur in ovulatory cycles, anovulatory cycles, or in a state of persistent follicles. The goal of treating DUB is to control acute bleeding, prevent future bleeding episodes, and reduce long-term risks like endometrial cancer by addressing any underlying anovulation. DUB is diagnosed by ruling out other potential organic causes through examination and testing. Treatment aims to stop bleeding either through medication or procedures like curettage. Prognosis depends on a patient's age and medical conditions.
AUB Diagnosis and evaluation BY: Dr. DIPTI NABH Dr Sharda Jain
This document discusses abnormal uterine bleeding (AUB) and provides guidelines for evaluating and diagnosing AUB. It summarizes the limitations of previous terminology for AUB and introduces the new PALM-COEIN classification system endorsed by FIGO and ACOG. The PALM-COEIN system provides a standardized terminology and classification for identifying structural or non-structural causes of AUB. The document then outlines the recommended steps for evaluating AUB, including history, physical exam, imaging tests like ultrasound and MRI, endometrial biopsy, and hysteroscopy.
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
MODERATOR : Dr. Ila Gupta
Dr. Sharda Jain
PANELIST : Dr. Jyoti Agarwal
Dr. Raj Bokaria
Dr. Dipti Nabh
Dr. Vandana Gupta
Abnormal uterine bleeding OBGYN CLERKSHIP LECTURE
This document discusses abnormal uterine bleeding (AUB), which refers to menstrual bleeding that differs in quantity, duration, or schedule from normal. AUB is a common gynecological complaint that can be caused by structural issues like fibroids or polyps, hormonal imbalances, or systemic diseases. The document outlines the evaluation, diagnosis, and treatment of AUB, including taking a medical history, performing exams and tests, considering potential etiologies, and treating underlying causes. Treatment depends on the identified cause and may involve medication, procedures like polypectomy, or surgery.
Sangrado anormal
Abnormal uterine bleeding (AUB) affects over 10 million women in the US and can impact daily life. AUB is classified as ovulatory or anovulatory bleeding. Evaluation involves endometrial biopsy, transvaginal ultrasound, hysteroscopy, and other techniques to identify potential causes like fibroids or polyps. Treatment options include medical therapies like hormones, NSAIDs, or ablation procedures. Surgical treatments range from removing lesions to hysterectomy or endometrial ablation. Proper evaluation and treatment selection depends on a woman's symptoms, age, and desire for future fertility.
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING BY DR SHASHWAT JANI
The document discusses medical management of abnormal uterine bleeding, focusing on progesterone. It provides background on abnormal uterine bleeding, including definitions, classification systems, evaluation, differential diagnoses, treatment options, and the roles of various hormones. The document specifically examines progesterone's role in hormonal regulation of the menstrual cycle and abnormal uterine bleeding. It also discusses various medical treatment options and when surgery may be indicated.
Abnormal uterine bleeding prof jamiyah hassan
This powerpoint presentation covers abnormal uterine bleeding, including its causes, classifications, investigations, and management. It discusses evaluating the endometrium and endometrial cavity, as well as medical treatments like the Mirena IUS, surgical treatments such as endometrial ablation and hysterectomy, and interventional treatments like uterine artery embolization. The goal of management is to exclude malignant causes, diagnose benign causes, and treat the condition based on factors like the patient's health, tolerance of medications, and future fertility plans.
What is Abnormal Uterine Bleeding?
Visit the document here, if you want to know what is abnormal uterine bleeding and what are the causes of it. Click the below link to know more: https://drsuparnabanerjee.com/aub.php
Abnormal Uterine Bleeding (AUB) -Etiopathogenesis
This document discusses the etiopathogenesis of abnormal uterine bleeding (AUB). AUB has various potential causes that are classified as organic (systemic, local/pelvic, iatrogenic) or dysfunctional (anovulatory, ovulatory). Dysfunctional uterine bleeding is further divided into anovulatory (80% of cases) and ovulatory (20% of cases). Anovulatory bleeding is caused by hormonal imbalances that prevent ovulation, while ovulatory bleeding results from issues with the luteal phase like insufficient progesterone support or prolonged luteal function. The pathophysiology involves an imbalance of prostaglandins produced by the endometrium in response to estrogen and progesterone levels.
AUB.Prof.Salah Roshdy
This document provides information on the evaluation and management of abnormal uterine bleeding (AUB). It begins with definitions of terms and classifications of AUB. Evaluation involves a history, physical exam, and testing as needed which may include ultrasound, hysteroscopy, or endometrial biopsy to determine the cause. Causes are categorized using the FIGO PALM-COEIN system. Treatment options discussed include general measures, medical therapies like hormones, NSAIDs, tranexamic acid, and surgical procedures such as endometrial ablation or hysterectomy. Non-hormonal and hormonal medical treatments are summarized. The document concludes with a discussion of progestin therapies.
1. aub (dr. nuru)
This document discusses abnormal uterine bleeding (AUB), including its definition, causes, evaluation, and diagnosis. Some key points:
- AUB is defined as any bleeding from the uterus that differs from a normal menstrual cycle in frequency, amount, or duration. It affects 10-30% of reproductive-aged women and up to 50% of perimenopausal women.
- Causes of AUB include pregnancy-related issues, infections, neoplasms, uterine conditions, systemic illnesses, iatrogenic factors, and dysfunctional uterine bleeding. Organic causes include lesions like fibroids, polyps, and cancers.
- Evaluation of AUB involves taking a medical history and performing exams and tests like ultrasound
Dysfunctional uterine bleeding
Dysfunctional uterine bleeding (DUB) is irregular bleeding that occurs without recognizable causes in the absence of pregnancy. It results from disruptions to the normal hormonal patterns that regulate the uterine lining. Bleeding episodes with DUB can be unpredictable in terms of duration, frequency, and amount. Laboratory tests and imaging studies are used to diagnose DUB and rule out other causes by examining thyroid function, prolactin levels, and pelvic imaging. Treatment involves pharmacologic options like oral contraceptives, estrogen, or progestins to suppress bleeding or reestablish normal cycles. Hysterectomy may be necessary for patients who do not respond to hormone therapy or experience quality of life issues from persistent bleeding.
Abnormal uterinebleeding
The document discusses new standardized terminology for abnormal uterine bleeding (AUB) developed by an international group of experts. Prior terminology for AUB was inconsistent and ambiguous. The new system, called PALM-COEIN, provides simple, descriptive definitions and a standardized classification system for causes of AUB. It aims to improve communication about AUB between clinicians and understanding for patients. The classification system categorizes causes of AUB into structural issues (PALM) or non-structural issues (COEIN) and provides guidelines for evaluation and management of AUB.
Management of not yet classified AUB..CESAREAN SCAR DEFECT,UTERINE ARTERIOV F...
A NEW APPROACH TO MANAGE ABN U BLEEDING,C S D,NOT YET CLASSIFIED CATEGORY.VAGINAL LIGATION UTERINE ARTERY
Transcervical Resection of Endometrium
Dysfunctional uterine bleeding (DUB) is the major cause of heavy menstrual bleeding and impacts on women’s health both medically and socially. First-line therapy has traditionally been medical therapy but this is frequently ineffective. On the other hand, hysterectomy is obviously 100% effective in stopping bleeding but is more costly and can cause severe complications and affect the quality of life. Endometrial ablation is less invasive and preserves the uterus and has shown to improve the quality of life indices.
More Related Content
What's hot
DUB
This document provides guidance on evaluating abnormal uterine bleeding through history, physical exam, laboratory tests, and imaging. It discusses evaluating for pregnancy, medical illnesses, bleeding disorders, and iatrogenic causes. Differential diagnoses are categorized as organic, dysfunctional, or iatrogenic. Dysfunctional uterine bleeding is considered a diagnosis of exclusion and can be ovulatory or anovulatory. Histopathological findings are described for conditions like irregular proliferation, luteal phase defects, and decidual shedding. Treatment aims and differential diagnoses are discussed based on a patient's age and menopausal status.
Abnormal Uterine Bleeding by Kemi Dele
The document discusses abnormal uterine bleeding, providing definitions and classifications including the PALM-COEIN system. It covers the evaluation, differential diagnosis, and management of abnormal uterine bleeding, both acute and chronic. The evaluation involves history, exam, labs, imaging and other tests to determine the cause, while management depends on whether it is acute or chronic and may involve medical options like hormones or surgery depending on the situation.
Abnormal uterine bleeding (AUB)
This document provides an overview of abnormal uterine bleeding (AUB), including its definition, causes, diagnosis, and treatment. It defines different types of AUB and outlines the FIGO classification system for causes. Common causes in young women include polycystic ovary syndrome (PCOS) and hypothalamic pituitary issues, while older women may experience fibroids, polyps or thyroid problems. Diagnosis involves history, exam, lab tests and imaging to rule out structural issues. Treatment depends on the underlying cause but commonly includes hormonal therapy, non-hormonal medications, endometrial ablation or hysterectomy. Long-term complications can include anemia and increased cancer risk.
ACUTE ABNORMAL UTERINE BLEEDING
1. Acute abnormal uterine bleeding (AUB) requires immediate intervention to prevent blood loss and is evaluated by assessing patient acuity, determining the likely etiology, and choosing appropriate treatment.
2. Initial assessment involves vital signs and signs of hypovolemia while etiologies consider medical history, medications, physical exam, and lab tests.
3. Treatment options for acute AUB include IV conjugated estrogen, intrauterine tamponade, combined oral contraceptives, antifibrinolytics, and surgery if medical options fail or are contraindicated. Long term options treat underlying causes.
Abnormal uterine bleeding
The document summarizes information about the menstrual cycle and abnormal uterine bleeding. It describes the typical phases and hormone levels during a normal menstrual cycle. It then defines and categorizes different types of abnormal uterine bleeding and lists potential structural and non-structural causes. The document outlines evaluation and treatment approaches, including general measures, medical management, minimally invasive procedures, and major surgery.
Abnormal uterine bleeding (aub)
Abnormal uterine bleeding (AUB) is irregular bleeding that occurs without recognizable cause. It reflects disrupted hormonal stimulation of the endometrial lining. AUB is common, especially in adolescents, perimenopausal women, and those with structural issues like polyps or fibroids. Evaluation involves history, exam, labs, and imaging to identify structural or non-structural causes. Treatment depends on severity but commonly includes medical options like birth control pills, NSAIDs, or hormonal drugs before considering surgery.
Abnormal uterine bleeding and Management
The document discusses abnormal uterine bleeding, including definitions of different types and potential causes. It covers evaluation and management of anovulatory bleeding at different reproductive stages. Evaluation may include imaging, biopsy, or testing for disorders. Management involves treating underlying causes, using hormones, or in some cases surgery. Surgical options like hysterectomy are usually only considered if medical management fails and childbearing is complete.
Ppt dub
Dysfunctional uterine bleeding (DUB) is the most common cause of abnormal uterine bleeding in women of reproductive age. DUB can occur in ovulatory cycles, anovulatory cycles, or in a state of persistent follicles. The goal of treating DUB is to control acute bleeding, prevent future bleeding episodes, and reduce long-term risks like endometrial cancer by addressing any underlying anovulation. DUB is diagnosed by ruling out other potential organic causes through examination and testing. Treatment aims to stop bleeding either through medication or procedures like curettage. Prognosis depends on a patient's age and medical conditions.
AUB Diagnosis and evaluation BY: Dr. DIPTI NABH Dr Sharda Jain
This document discusses abnormal uterine bleeding (AUB) and provides guidelines for evaluating and diagnosing AUB. It summarizes the limitations of previous terminology for AUB and introduces the new PALM-COEIN classification system endorsed by FIGO and ACOG. The PALM-COEIN system provides a standardized terminology and classification for identifying structural or non-structural causes of AUB. The document then outlines the recommended steps for evaluating AUB, including history, physical exam, imaging tests like ultrasound and MRI, endometrial biopsy, and hysteroscopy.
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
MODERATOR : Dr. Ila Gupta
Dr. Sharda Jain
PANELIST : Dr. Jyoti Agarwal
Dr. Raj Bokaria
Dr. Dipti Nabh
Dr. Vandana Gupta
Abnormal uterine bleeding OBGYN CLERKSHIP LECTURE
This document discusses abnormal uterine bleeding (AUB), which refers to menstrual bleeding that differs in quantity, duration, or schedule from normal. AUB is a common gynecological complaint that can be caused by structural issues like fibroids or polyps, hormonal imbalances, or systemic diseases. The document outlines the evaluation, diagnosis, and treatment of AUB, including taking a medical history, performing exams and tests, considering potential etiologies, and treating underlying causes. Treatment depends on the identified cause and may involve medication, procedures like polypectomy, or surgery.
Sangrado anormal
Abnormal uterine bleeding (AUB) affects over 10 million women in the US and can impact daily life. AUB is classified as ovulatory or anovulatory bleeding. Evaluation involves endometrial biopsy, transvaginal ultrasound, hysteroscopy, and other techniques to identify potential causes like fibroids or polyps. Treatment options include medical therapies like hormones, NSAIDs, or ablation procedures. Surgical treatments range from removing lesions to hysterectomy or endometrial ablation. Proper evaluation and treatment selection depends on a woman's symptoms, age, and desire for future fertility.
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING BY DR SHASHWAT JANI
The document discusses medical management of abnormal uterine bleeding, focusing on progesterone. It provides background on abnormal uterine bleeding, including definitions, classification systems, evaluation, differential diagnoses, treatment options, and the roles of various hormones. The document specifically examines progesterone's role in hormonal regulation of the menstrual cycle and abnormal uterine bleeding. It also discusses various medical treatment options and when surgery may be indicated.
Abnormal uterine bleeding prof jamiyah hassan
This powerpoint presentation covers abnormal uterine bleeding, including its causes, classifications, investigations, and management. It discusses evaluating the endometrium and endometrial cavity, as well as medical treatments like the Mirena IUS, surgical treatments such as endometrial ablation and hysterectomy, and interventional treatments like uterine artery embolization. The goal of management is to exclude malignant causes, diagnose benign causes, and treat the condition based on factors like the patient's health, tolerance of medications, and future fertility plans.
What is Abnormal Uterine Bleeding?
Visit the document here, if you want to know what is abnormal uterine bleeding and what are the causes of it. Click the below link to know more: https://drsuparnabanerjee.com/aub.php
Abnormal Uterine Bleeding (AUB) -Etiopathogenesis
This document discusses the etiopathogenesis of abnormal uterine bleeding (AUB). AUB has various potential causes that are classified as organic (systemic, local/pelvic, iatrogenic) or dysfunctional (anovulatory, ovulatory). Dysfunctional uterine bleeding is further divided into anovulatory (80% of cases) and ovulatory (20% of cases). Anovulatory bleeding is caused by hormonal imbalances that prevent ovulation, while ovulatory bleeding results from issues with the luteal phase like insufficient progesterone support or prolonged luteal function. The pathophysiology involves an imbalance of prostaglandins produced by the endometrium in response to estrogen and progesterone levels.
AUB.Prof.Salah Roshdy
This document provides information on the evaluation and management of abnormal uterine bleeding (AUB). It begins with definitions of terms and classifications of AUB. Evaluation involves a history, physical exam, and testing as needed which may include ultrasound, hysteroscopy, or endometrial biopsy to determine the cause. Causes are categorized using the FIGO PALM-COEIN system. Treatment options discussed include general measures, medical therapies like hormones, NSAIDs, tranexamic acid, and surgical procedures such as endometrial ablation or hysterectomy. Non-hormonal and hormonal medical treatments are summarized. The document concludes with a discussion of progestin therapies.
1. aub (dr. nuru)
This document discusses abnormal uterine bleeding (AUB), including its definition, causes, evaluation, and diagnosis. Some key points:
- AUB is defined as any bleeding from the uterus that differs from a normal menstrual cycle in frequency, amount, or duration. It affects 10-30% of reproductive-aged women and up to 50% of perimenopausal women.
- Causes of AUB include pregnancy-related issues, infections, neoplasms, uterine conditions, systemic illnesses, iatrogenic factors, and dysfunctional uterine bleeding. Organic causes include lesions like fibroids, polyps, and cancers.
- Evaluation of AUB involves taking a medical history and performing exams and tests like ultrasound
Dysfunctional uterine bleeding
Dysfunctional uterine bleeding (DUB) is irregular bleeding that occurs without recognizable causes in the absence of pregnancy. It results from disruptions to the normal hormonal patterns that regulate the uterine lining. Bleeding episodes with DUB can be unpredictable in terms of duration, frequency, and amount. Laboratory tests and imaging studies are used to diagnose DUB and rule out other causes by examining thyroid function, prolactin levels, and pelvic imaging. Treatment involves pharmacologic options like oral contraceptives, estrogen, or progestins to suppress bleeding or reestablish normal cycles. Hysterectomy may be necessary for patients who do not respond to hormone therapy or experience quality of life issues from persistent bleeding.
What's hot (19)
AUB Diagnosis and evaluation BY: Dr. DIPTI NABH Dr Sharda Jain
AUB Diagnosis and evaluation BY: Dr. DIPTI NABH Dr Sharda Jain
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING BY DR SHASHWAT JANI
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING BY DR SHASHWAT JANI
Similar to Abnormal uterine bleeding definition end of cofusion
Abnormal uterinebleeding
The document discusses new standardized terminology for abnormal uterine bleeding (AUB) developed by an international group of experts. Prior terminology for AUB was inconsistent and ambiguous. The new system, called PALM-COEIN, provides simple, descriptive definitions and a standardized classification system for causes of AUB. It aims to improve communication about AUB between clinicians and understanding for patients. The classification system categorizes causes of AUB into structural issues (PALM) or non-structural issues (COEIN) and provides guidelines for evaluation and management of AUB.
Management of not yet classified AUB..CESAREAN SCAR DEFECT,UTERINE ARTERIOV F...
A NEW APPROACH TO MANAGE ABN U BLEEDING,C S D,NOT YET CLASSIFIED CATEGORY.VAGINAL LIGATION UTERINE ARTERY
Transcervical Resection of Endometrium
Dysfunctional uterine bleeding (DUB) is the major cause of heavy menstrual bleeding and impacts on women’s health both medically and socially. First-line therapy has traditionally been medical therapy but this is frequently ineffective. On the other hand, hysterectomy is obviously 100% effective in stopping bleeding but is more costly and can cause severe complications and affect the quality of life. Endometrial ablation is less invasive and preserves the uterus and has shown to improve the quality of life indices.
Aub
This document discusses abnormal uterine bleeding (AUB) and provides information on evaluating and managing AUB. It introduces the PALM-COEIN classification system for causes of AUB, which categorizes causes into 9 groups based on structural vs non-structural entities. Evaluation of AUB involves medical history, physical exam, lab tests, imaging and procedures to determine the cause. Treatment depends on the cause but may include NSAIDs, antifibrinolytic agents, or danazol to reduce bleeding through various mechanisms of action.
Aub for tomorrow
This document discusses abnormal uterine bleeding (AUB) and provides information on evaluating and managing AUB. It introduces the PALM-COEIN classification system for causes of AUB, which categorizes causes into 9 groups based on their acronym. The document describes approaches to diagnosing AUB, including medical history, physical exam, lab tests, imaging and procedures. It outlines treatment options for AUB including nonsteroidal anti-inflammatory drugs, antifibrinolytic agents, and danazol to reduce bleeding.
Abnormal uterine bleeding in premenopausal age.docx
Premenopausal bleeding can be due to structural causes (polyps, adenomyosis, leiomyomas, malignancy) or non-structural causes (coagulopathy, ovulatory dysfunction, endometrial factors, iatrogenic, or “not otherwise classified”.)
ABNORMAL UTERINE BLEEDING- WHAT IS NEW ?
This document discusses abnormal uterine bleeding (AUB), including definitions, prevalence, assessment, causes, and management. Some key points:
- AUB is irregular bleeding that affects 10-30% of reproductive-aged women. It has many potential causes and can seriously impact quality of life.
- Assessment involves history, physical exam, blood tests, imaging like ultrasound and potentially biopsy. The Pictorial Blood Assessment Chart scores bleeding to indicate if it is heavy.
- Causes vary by age but include issues like fibroids, polyps, hormonal imbalances, and cancer. The 2018 FIGO classification system standardized terminology.
- Initial treatment is usually medical like hormones, NSAIDs, or tran
Perimenopausal Bleeding a Pragmatic Approach
This document lists the professional qualifications and positions held by Dr. Laxmi Shrikhande, including Chairperson for various medical committees, publications, awards received, and presentations given. It then provides an overview of her upcoming presentation on Perimenopausal Bleeding, covering definitions, classifications, evaluation, treatment options for structural and non-structural causes, and specific treatment approaches like hormonal therapy, NSAIDs, and levonorgestrel intrauterine devices.
Aub prof.Salah Roshdy@
This document provides definitions and guidelines for the diagnosis and management of abnormal uterine bleeding (AUB). It summarizes the phases of the normal menstrual cycle and defines AUB as any variation from normal cycles in regularity, frequency, duration, or blood loss. AUB is a common reason for gynecologic consultation, responsible for over 1/3 of hysterectomies. The document outlines the PALM-COEIN classification system for AUB and recommendations for initial diagnostic tests including transvaginal ultrasound, hysteroscopy, and endometrial biopsy based on patient history and risk factors.
Step wise pelvic devascularisation
Systematic pelvic devascularisation is an effective and uterus conserving surgical method to control PPH.
Abnormal Uterine Bleeding (AUB).pptx
This document discusses abnormal uterine bleeding (AUB), providing definitions, terminology, and etiologies. It describes the normal menstrual cycle and defines AUB as bleeding that is abnormal in duration, volume, frequency, or regularity. Common etiologies of AUB are organized using the PALM-COEIN system, including structural issues like polyps, adenomyosis, and leiomyomas. Diagnosis involves taking a history, examining the patient, and running targeted tests. Treatment for acute AUB focuses on stabilization, while chronic AUB may be treated with medical options, procedures, or surgery depending on the individual.
Abnormal uterine bleeding .pptx
This document provides information on the FIGO classification system for abnormal uterine bleeding (AUB). It discusses the definition of AUB and introduces the two FIGO classification systems: System 1 which categorizes AUB based on bleeding patterns, and System 2 which categorizes AUB into nine etiological categories called PALM-COEIN. For each category, the document provides details on evaluation and management. The goal of the FIGO classification systems is to standardize terminology and guide clinical practice for AUB.
Laparoscopic ovarian drilling(LOD)
Recent evidence based guideline regarding Ovarian drilling very helpful for Gynaecologist, laparoscopic surgeon, Infertility specialist, Post doctoral fellows and post graduates
Palm coein clasification
The document discusses the new FIGO classification system for abnormal uterine bleeding (AUB). It introduces the PALM-COEIN system which provides a standardized terminology and classification. The system categorizes AUB into structural causes (polyps, adenomyosis, leiomyoma, malignancy) and non-structural causes (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not yet classified). It provides guidelines for evaluation and outlines the notation system for documenting multiple contributing factors to a patient's AUB. The standardized classification aims to improve management of AUB internationally through a unified terminology and focus on appropriate treatment concepts.
Insight AUB Management Guidelines on AUB in Reproductive Period
Insight AUB
Evidence based on --- FOGSI AUB guidelines
10TH JUNE DEHRADOON ,
15TH SEPTEMBER , Delhi (D.G.F. CME)
DR. JYOTI BHASKAR
MD MRCOG PGDMLS
Insight AUB Management Guidelines on AUB in Reproductive Period
Evidence based on --- FOGSI AUB guidelines
10TH JUNE DEHRADOON ,
15TH SEPTEMBER , Delhi (D.G.F. CME)
DR. JYOTI BHASKAR
MD MRCOG PGDMLS
Disorders of the menstrual cycle 1
Heavy menstrual bleeding (HMB) is defined as blood loss greater than 80 mL per period. A clinical diagnosis based on a patient's perception of blood loss is preferred, as methods to quantify blood loss are inaccurate and impractical. Common causes of HMB include fibroids, polyps, coagulation disorders, and thyroid disease. Initial investigations include a full blood count, coagulation screen if a disorder is suspected, and thyroid tests if suggested by history. Ultrasound can identify masses like fibroids, and endometrial biopsy may be needed if medical treatments fail or irregular bleeding is present. Treatments range from medications to reduce bleeding to surgical options like endometrial ablation or hysterectomy if medications are ineffective.
Management of Endometrioma- Current Update
Invited Lecture by Dr Sujoy Dasgupta in the Webinar on "Update on Endometriosis" organized by AICC RCOG (All India Coordinating Committee of Royal College of Obstetricians and Gynaecologists) East Zone, held in December, 2021
Management of Endometrioma associated infertility
This document discusses the management of endometriosis associated infertility. It begins with the incidence and diagnosis of endometriosis and endometriomas. It then discusses treatment options including IVF, surgery, and aspiration. IVF is recommended as the first line treatment, as the presence of an endometrioma does not negatively impact IVF outcomes. Surgery is not recommended prior to IVF unless needed for pain or inability to access follicles. Aspiration is not recommended before IVF except in cases where an endometrioma may hinder oocyte retrieval. The conclusion cites French guidelines that found no impact of endometriomas on IVF results, and recommends against pre-IVF surgery or asp
Aub in adolescents edit2
This document provides a summary of the qualifications and experience of Dr. Manju Gita Mishra. She is a former professor of obstetrics and gynecology with over 70 publications. Her areas of special interest include high risk pregnancy, adolescent gynecology, and emergency obstetrics. She has held several leadership positions in obstetrics and gynecology organizations and has received several awards for her contributions to the field.
Similar to Abnormal uterine bleeding definition end of cofusion (20)
Management of not yet classified AUB..CESAREAN SCAR DEFECT,UTERINE ARTERIOV F...
Management of not yet classified AUB..CESAREAN SCAR DEFECT,UTERINE ARTERIOV F...
Abnormal uterine bleeding in premenopausal age.docx
Abnormal uterine bleeding in premenopausal age.docx
Insight AUB Management Guidelines on AUB in Reproductive Period
Insight AUB Management Guidelines on AUB in Reproductive Period
Insight AUB Management Guidelines on AUB in Reproductive Period
Insight AUB Management Guidelines on AUB in Reproductive Period
Recently uploaded
10 Benefits an EPCR Software should Bring to EMS Organizations
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
vonoprazan A novel drug for GERD presentation
Vonoprazan, a new potassium acid channel blocker used in the conditions of GERD and gastric ulcer, duodenal ulcer ....
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
DECLARATION OF HELSINKI - History and principles
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
This quiz was conducted as a promotional event for the 2024 Annual Meet of Kerala Chapter of API.
More than 20 participants took part everyday !
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
Recently uploaded (20)
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Abnormal uterine bleeding definition end of cofusion
- 1. Probably END of confusion in classification of menstrual disorders in woman BAIDYA JL DEPARTMENT OF OBSTETRICS & GYNAECOLOGY AGMC
- 2. Literature search on menstrual disorders More than 90 k
- 3. Back ground of talk Confusion regarding terminologies that used Confusion in classifying the aetiologies of AUB Confusion regarding investigations Confusion in treatment protocol Confusion in research
- 4. Menstrual disorder Menstrual disorders are a common indication for medical visits among women of reproductive age and heavy menstrual bleeding affects up to 30% of women throughout their reproductive lifetime. These complaints may significantly affect quality of life, result in time off work, lead to surgical intervention including hysterectomy, and ultimately have a significant impact on the health care system.
- 5. Introduction Standardized universal terminology is essential To improve communication among practitioners and to help guide research and education on this topic. Review of current terminology in medical and historical literature reveals confusing and inconsistent definitions referring to menstrual bleeding
- 6. Hence FIGO Menstrual Disorders Working Group (an international expert consensus committee) has developed new guidelines for terminology related to this topic Redefined & reclassified menstrual disorders in women
- 7. History Supported by ACOG (Practice Bulletin No. 128, July 2012) 2009 FIGO accepted the new terminology: PALM-COEIN classification system created 2006 FIGO identified appropriate group- FIGO Menstrual Disorder 2005 historic review & recommendations by 35 experts
- 8. Discarded terminologies Menorrhagia, Hypermenorrhea,Hypomenorrhea Menometrorrhagia, Polymenorrhea Polymenorrhagia Epimenorrhea, Epimenorrhagia, Uterine hemorrhage Dysfunctional uterine bleeding, Functional uterine bleeding, Metropathica hemorrhagica Oligomenorrhea *Amenorrhea – retained term
- 9. Definition of AUB AUB may be defined as any variation from the normal menstrual cycle, and includes changes in regularity and frequency of menses, in duration of flow, or in amount of blood loss.
- 10. ACCEPTED TERMINOLOGY(FIGO 2012) AUB- Abnormal Uterine Bleeding HMB- Heavy Menstrual Bleeding (that interferes with the quality of life) (ovulatory) HPMB- Heavy and Prolonged Menstrual Bleeding IMB- Intermenstrual Bleeding (bleeding between clearly defined cyclical menses) PMB- Post Menopausal Bleeding
- 11. Terminology of AUB Volume Regularity Frequency Duration Others Heavy Irregular Frequent Prolonged Intermenstrual Normal Regular Normal Normal Pre mentrual Light Absent Infrequent Shortened breakthrough
- 14. View point…end of confusion There has been a considerable worldwide confusion about the various terminologies about AUB causing difficulties in planning and conducting proper studies and in comparing results of different studies. The FIGO initiative about uniform classification for AUB is laudable and hopefully shall become successful like their FIGO classification of various gynaecological cancers, which have been universally accepted throughout the world
- 15. View point…… contd. The FIGO classification is regarded as a flexible “living” document that should undergo review and consideration for modification at regular intervals. Special editorial by Dr. Munro, Dr. Hilary O. D. Critchley, and Dr. Ian S. Fraser
- 16. thanks